Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
This guide discusses withdrawal rate decisions for an index fund portfolio in retirement, including portfolio diversification and contingency planning.
23,394 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Meme coins grab headlines and wallets alike. This guide dives into Dogecoin and Pepe, breaking down what makes each t...
A whispered cornerstone of Warren Buffett's private investing approach is said to lead the pack in a $786 million sec...
Temasek unveils a sweeping leadership overhaul, elevating its CFO into a central strategic role as the group reorgani...
In 2026, investors face a choice between a global industrial leader and a defense-focused specialist. This guide brea...
Berkshire Hathaway’s surprise Alphabet investment signals a bold, long-term bet from Buffett. Learn the reasoning, ri...
USOI, a Credit Suisse X-Links Crude Oil ETN, pays sizable monthly distributions but sits in the risky space of unsecu...
Spot Bitcoin ETFs are drawing record flows in 2026, with IBIT and FBTC leading liquidity. Here’s how to pick which bi...
A growing share of veterans aging in place face repairs and accessibility gaps that threaten stable housing. Experts ...
Venture funding in the U.S. hit a record in the first half of 2026, led by AI mega-deals, while exits skew toward Spa...
As the auto industry pivots to software and batteries, investors must pick between a giant with scale and a high-grow...
A stock delivering a 7% dividend yield and yet slipping 20% year-to-date may seem puzzling. This guide explains how t...